AI Transforming Drug Discovery: Next Biotech Boom Ahead
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
This page features valuable insights on AI in healthcare, including top stock recommendations. Stay informed to make smarter financial decisions.
17 articlesArtificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
As cost controls tighten, doctors and AI are pressing to restore clinician-led care. Investors are watching insurers’...
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
U.S. health insurers rise as analysts forecast margin recovery and cost discipline. Humana jumps, UnitedHealth climbs...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
Doximity has stumbled this year, dropping as investors worry about AI competition and growth. This guide lays out a c...
U.S. healthcare equities rise as firms deploy agentic AI to cut labor costs, lifting a group of AI-enabled healthcare...
AI-enabled surgical robotics are turning hospitals into data hubs. Intuitive Surgical, Medtronic, and Stryker sit at ...
Q1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...